Cargando…
Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease
Alzheimer’s Disease (AD) is the most common cause of dementia, affecting approximately two thirds of the 35 million people worldwide with the condition. Despite this, effective treatments are lacking, and there are no drugs that elicit disease modifying effects to improve outcome. There is an urgent...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817602/ https://www.ncbi.nlm.nih.gov/pubmed/24275851 http://dx.doi.org/10.3390/ph6101304 |